	US 12,331,323 B1
	Composition for regulating production of fusion proteins
Bradley G. Thompson, Calgary (CA)
Assigned to ERAD Therapeutics Canada Inc., Caledon (CA)
Filed by ERAD Therapeutics Canada Inc., Caledon (CA)
Filed on Sep. 16, 2024, as Appl. No. 18/885,902.
Int. Cl. C12N 15/86 (2006.01); C07K 14/28 (2006.01); C12N 7/00 (2006.01); C12N 15/33 (2006.01); C12N 15/864 (2006.01)

CPC C12N 7/00 (2013.01) [C07K 14/28 (2013.01); C12N 2750/14122 (2013.01); C12N 2750/14143 (2013.01)]

4 Claims

1. A composition that comprises a recombinant plasmid (RP) with a sequence of nucleotides that encodes a messenger ribonucleic acid (mRNA) sequence that encodes modified Cholera toxin A and Cholera toxin B, and wherein the sequence of nucleotides is about 95% to about 100% identical to the nucleotide sequence of SEQ ID NO: 2.